Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting
economically active young adults, and has high mortality irrespective of HIV status. In some …

Following large-scale roll-out of antiretroviral therapy in sub-Saharan Africa, the non-clinical
efficacy of antiretroviral therapy has received little attention. We aimed to systematically …

Rationale: The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) epidemics are rapidly expanding in South Africa. Our initial report of HIV-associated …

Despite policies, strategies, and guidelines, the epidemic of HIV-associated tuberculosis
continues to rage, particularly in southern Africa. We focus our attention on the regions with …

Sub-Saharan Africa is experiencing a multiple disease burden. Noncommunicable diseases
(NCDs) are emerging, and their risk factors are becoming more common as lifestyles …

Summary Background Data from Kwazulu Natal, South Africa, suggest that almost all
patients with extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal …

Background In some low‐and middle‐income countries, separate vertical programmes
deliver specific life‐saving interventions but can fragment services. Strategies to integrate …

The rollout of antiretroviral therapy (ART) significantly reduced human immunodeficiency
virus (HIV)-related morbidity and mortality, but good clinical outcomes depend on access …

OBJECTIVE: To establish estimates of viral suppression in low-and middle-income countries
(LMICs) in patients who received antiretroviral therapy (ART) for human immunodeficiency …

Objectives Given the imperative to scale up integrated tuberculosis (TB) and HIV services in
settings where both are of major public health importance, we aimed to synthesise …